S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Completed · Phase 2

Conditions studied: Adult Meningioma

In brief

RATIONALE: Drugs used in chemotherapy such as hydroxyurea use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well hydroxyurea works in treating patients with unresectable benign meningioma.

Key facts

Study ID
NCT00003590
Run by
SWOG Cancer Research Network
People needed
29
Starts
1998-11-01
Expected to finish
2011-07-01
Last updated by the study team
2016-05-20

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.